Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31447 ↗At a glance
Multizentrische Studie in Catheterization and Cardiovascular Interventions, 2025. Written by Peter Evans and 4 co-authors. Institution: Boston University Medical Center, Boston, Massachusetts, USA. Major MEDLINE topics: Peripheral Arterial Disease, Renal Insufficiency, Chronic, Femoral Artery, Endovascular Procedures. Cited 4 times so far (Crossref); 42 references. The full text is freely available in PubMed Central. Funded by: CSRD VA, This study was supported by a VA Clinical Science Research and Development Award 1/01CX001549..
Abstract (original language)
Background
Chronic kidney disease (CKD) is associated with worse outcomes in peripheral artery disease (PAD). The impact of the severity of CKD on mortality and major adverse limb events (MALE) after endovascular revascularization of the superficial femoral artery (SFA) is unknown.
Aims
To assess the relationship of increasing severity of CKD on the risk of mortality and MALE in patients after endovascular revascularization of the SFA.
Methods
We followed a cohort of 202 patients (253 limbs) with SFA endovascular revascularization for claudication or chronic limb‐threatening ischemia in two academic centers between 2003 and 2011. Patients were categorized into four Kidney Disease Improving Global Outcomes (KDIGO) categories of increasingly worse CKD based on estimated glomerular filtration rate (eGFR). The primary outcome was all‐cause death. Secondary outcomes included cardiovascular death, noncardiovascular death, and MALE. The relationship between CKD severity and outcomes was assessed by hazard ratios (HR) and 95% confidence intervals (95%CI) from cause‐specific multivariable Cox proportional hazards models and Fine‐Gray competing risks analyses.
Results
During a median follow‐up of 9.3 years, there was a graded and increasing risk of all‐cause, cardiovascular, and noncardiovascular mortality with worse eGFR (all tests of trend p < 0.001). The lowest eGFR category (< 45 mL/min/1.73 m²) was associated with the highest risk of all‐cause mortality (HR = 5.0, 95% CI = 2.4, 10), cardiovascular mortality (HR = 5.8, 95% CI = 1.8, 18), and noncardiovascular mortality (HR = 4.5, 95% CI = 1.9, 11). There was no significant association between CKD severity and MALE or minor revascularization events.
Conclusion
The risk of mortality risk after SFA endovascular revascularization incrementally increases with decreasing renal function. However, impaired renal function is not related to the risk of adverse limb events and supports femoral revascularization in these patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Boston University Medical Center, Boston, Massachusetts, USA.
- Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA.
- Boston University School of Medicine, Boston, Massachusetts, USA.
- Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Previously Brigham and Women's Hospital, Boston, Massachusetts, USA.
ORCID profiles: Peter Evans, Scott Kinlay
Funding
- CSRD VA
- This study was supported by a VA Clinical Science Research and Development Award 1/01CX001549.
Cite
APA
Evans, P., Sobieszczyk, P., Eisenhauer, A. C., Todoran, T. M., & Kinlay, S. (2025). Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31447
Vancouver
Evans P, Sobieszczyk P, Eisenhauer AC, Todoran TM, Kinlay S. Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31447
BibTeX
@article{Evans2025,
author = {Evans, Peter and Sobieszczyk, Piotr and Eisenhauer, Andrew C and Todoran, Thomas M and Kinlay, Scott},
title = {Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31447}
}
EUVIMED